In LIHC, DCAF7 correlated strongly with PD‐1/PD‐L1 and CTLA‐4 expression, implying that tumours with elevated DCAF7 might preferentially exploit checkpoint pathways for immune evasion and could therefore benefit from dual targeting of DCAF7‐driven signalling and checkpoint blockade. The gene discussed is CD274; the disease is neoplasm.